Literature DB >> 33639570

Sex differences in US emergency department non-fatal visits for benzodiazepine poisonings in adolescents and young adults.

Greta A Bushnell1, Mark Olfson2, Silvia S Martins3.   

Abstract

BACKGROUND: Benzodiazepine (BZD)-related overdose deaths have risen in the past decade and BZD misuse contributes to thousands of emergency department (ED) visits annually, with the highest rates in adolescents and young adults. Because there are gaps in understanding BZD poisoning in youth and whether differences occur by sex, we aimed to characterize BZD poisoning ED visits in young people by sex.
METHODS: BZD poisoning visits were identified in the Nationwide Emergency Department Sample, among adolescents (12-17 years) and young adults (18-29 years). Stratified by sex and age, we described ED visits for BZD poisonings in 2016, including poisoning intent, concurrent substances involved, and co-occurring mental health disorder diagnoses. With logistic regression we examined the association between intent and concurrent substance.
RESULTS: There were approximately 38,000 BZD poisoning ED visits by young people nationwide with annual population rates per 10,000 of 2.9=adolescents and 5.8=young adults. Depression was diagnosed in 40 % of female and 23 % of male BZD visits (p < 0.01). Over half of BZD poisonings in females and a third in males were intentional (p < 0.01). Male BZD visits were more likely to involve opioids or cannabis and less likely to involve antidepressants than females (p-values<0.01). In males and females, BZD poisonings concurrent with antidepressants and other psychotropic medications were more likely to be intentional than unintentional (OR range:2.1-6.3).
CONCLUSIONS: The high proportion of BZD poisonings that are intentional and include mental health disorder diagnoses, especially among young females, underscore the importance of ED mental health and suicide risk assessment with appropriate follow-up referral.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescents; Benzodiazepine; Emergency department; Poisoning; Sex

Mesh:

Substances:

Year:  2021        PMID: 33639570      PMCID: PMC8482968          DOI: 10.1016/j.drugalcdep.2021.108609

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

1.  Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008.

Authors:  R Cai; E Crane; K Poneleit; L Paulozzi
Journal:  J Pain Palliat Care Pharmacother       Date:  2010-09

2.  Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States.

Authors:  Carlos Blanco; Beth Han; Christopher M Jones; Kimberly Johnson; Wilson M Compton
Journal:  J Clin Psychiatry       Date:  2018-10-16       Impact factor: 4.384

3.  Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health.

Authors:  Sarah P Haughwout; Thomas C Harford; I-Jen P Castle; Bridget F Grant
Journal:  Alcohol Clin Exp Res       Date:  2016-07-18       Impact factor: 3.455

4.  Benzodiazepine Use and Misuse Among Adults in the United States.

Authors:  Donovan T Maust; Lewei A Lin; Frederic C Blow
Journal:  Psychiatr Serv       Date:  2018-12-17       Impact factor: 3.084

5.  ED visits for drug-related poisoning in the United States, 2007.

Authors:  Yuxi Xiang; Weiyan Zhao; Huiyun Xiang; Gary A Smith
Journal:  Am J Emerg Med       Date:  2011-03-02       Impact factor: 2.469

6.  Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.

Authors:  Sean Esteban McCabe; Timothy E Wilens; Carol J Boyd; Kao-Ping Chua; Terri Voepel-Lewis; Ty S Schepis
Journal:  Addict Behav       Date:  2018-11-14       Impact factor: 3.913

7.  Suicide Prevention in an Emergency Department Population: The ED-SAFE Study.

Authors:  Ivan W Miller; Carlos A Camargo; Sarah A Arias; Ashley F Sullivan; Michael H Allen; Amy B Goldstein; Anne P Manton; Janice A Espinola; Richard Jones; Kohei Hasegawa; Edwin D Boudreaux
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

8.  Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors.

Authors:  Sean Esteban McCabe; Brady T West
Journal:  Addict Behav       Date:  2014-01-28       Impact factor: 3.913

Review 9.  Our future: a Lancet commission on adolescent health and wellbeing.

Authors:  George C Patton; Susan M Sawyer; John S Santelli; David A Ross; Rima Afifi; Nicholas B Allen; Monika Arora; Peter Azzopardi; Wendy Baldwin; Christopher Bonell; Ritsuko Kakuma; Elissa Kennedy; Jaqueline Mahon; Terry McGovern; Ali H Mokdad; Vikram Patel; Suzanne Petroni; Nicola Reavley; Kikelomo Taiwo; Jane Waldfogel; Dakshitha Wickremarathne; Carmen Barroso; Zulfiqar Bhutta; Adesegun O Fatusi; Amitabh Mattoo; Judith Diers; Jing Fang; Jane Ferguson; Frederick Ssewamala; Russell M Viner
Journal:  Lancet       Date:  2016-05-09       Impact factor: 79.321

10.  Incidence and Lethality of Suicidal Overdoses by Drug Class.

Authors:  Ted R Miller; David I Swedler; Bruce A Lawrence; Bina Ali; Ian R H Rockett; Nancy N Carlson; Jennifer Leonardo
Journal:  JAMA Netw Open       Date:  2020-03-02
View more
  4 in total

1.  Long-term Psychoactive Medications, Polypharmacy, and Risk of Suicide and Unintended Overdose Death Among Midlife and Older Women Veterans.

Authors:  Carolyn J Gibson; Yixia Li; Guneet K Jasuja; Salomeh Keyhani; Amy L Byers
Journal:  J Gen Intern Med       Date:  2022-08-30       Impact factor: 6.473

2.  Suicidal Behavior and Its Relationship with Postmortem Forensic Toxicological Findings.

Authors:  Aurelia Collados-Ros; Carmen Torres-Sánchez; María Dolores Pérez-Cárceles; Aurelio Luna; Isabel Legaz
Journal:  Toxics       Date:  2022-06-11

3.  Application of Machine Learning Techniques to Help in the Feature Selection Related to Hospital Readmissions of Suicidal Behavior.

Authors:  Gema Castillo-Sánchez; Mario Jojoa Acosta; Begonya Garcia-Zapirain; Isabel De la Torre; Manuel Franco-Martín
Journal:  Int J Ment Health Addict       Date:  2022-07-18       Impact factor: 11.555

4.  Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use.

Authors:  Irene Mattioli; Alessandra Bettiol; Niccolò Lombardi; Alfredo Vannacci; Giada Crescioli; Roberto Bonaiuti; Domenico Prisco; Guido Mannaioni
Journal:  Eur J Clin Pharmacol       Date:  2022-06-22       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.